Neuropeptide Y and derivates are not ready for prime time in prostate cancer early detection
Neuropeptide Y (NPY) and related peptides have been proposed as promising biomarkers for the diagnosis of prostate cancer by previous immunoassays and immunohistochemical studies. In this study, we evaluated the additional value of NPY and related peptides compared with prostate-specific antigen (PS...
Hlavní autoři: | Maurer, J, Eugster, PJ, Collins, K, Vocat, C, Oke, J, Nicholson, B, Rakauskas, A, Grouzmann, E, Valerio, M |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Elsevier
2024
|
Podobné jednotky
-
Neuropeptide Y and Derivates Are Not Ready for Prime Time in Prostate Cancer Early Detection
Autor: Jonathan Maurer, a další
Vydáno: (2024-08-01) -
Genomic Testing for Advanced Prostate Cancer: Ready for Prime Time?
Autor: Alexander Meisel
Vydáno: (2019-12-01) -
Saxagliptin: A potential doping agent? A randomized, double‐blinded, placebo‐controlled, and crossover pilot study in young active men
Autor: Nicolas Bourdillon, a další
Vydáno: (2022-12-01) -
Biomarkers in early-stage colorectal cancer: ready for prime time?
Autor: Church, D, a další
Vydáno: (2012) -
REBOA: is it ready for prime time?
Autor: Jay Doucet, a další